Results 171 to 180 of about 21,294 (218)

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study [PDF]

, 2018
et al,, Gambacorti-Passerini, Carlo, Van Tine, Brian A   +2 more
core   +1 more source

Perioperative Strategies in Resectable Non-Squamous Non-Small Cell Lung Cancer with EGFR Mutations and ALK Rearrangement. [PDF]

Cancers (Basel)
Petrella F, Cara A, Cassina EM, Degiovanni S, Libretti L, Lo Torto S, Pirondini E, Raveglia F, Spinelli F, Tuoro A, Rizzo S.   +10 more
europepmc   +1 more source

Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review. [PDF]

Onco Targets Ther, 2021
Gu R, Shi Z, Duan T, Song M.
europepmc   +1 more source

Prognostic impact of <i>ALK</i> rearrangement in surgically treated stage I lung adenocarcinoma: a retrospective cohort study. [PDF]

Transl Lung Cancer Res
Huang Y, Zhou J, Shen C, Yang R, Zheng Q, Qiu Y, Mei X, Wu K, Wu D, Wang J, Jiang W, Liao H.   +11 more
europepmc   +1 more source

Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario. [PDF]

BMC Cancer, 2021
Nadal E, Bautista D, Cabezón-Gutiérrez L, Ortega AL, Torres H, Carcedo D, Ruiz de Alda L, Garcia JF, Vieitez P, Rojo F.   +9 more
europepmc   +1 more source

A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement. [PDF]

Front Pharmacol
Zheng Y, Zhao F, Ren Y, Xue Y, Yan B, Huang C.   +5 more
europepmc   +1 more source

Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report. [PDF]

Front Pharmacol, 2022
Zhao J, Li X, Fan R, Qin Y, Wang Z, Wang B, Li S, Fan J, Wu X, Liu H, Guan Y, Liang Y, Zhang X, Guo Y.   +13 more
europepmc   +1 more source

Are all ALK rearrangements created equal?

Translational Cancer Research, 2017
Michael Duruisseaux, Anne Mc Leer-Florin, Denis Moro-Sibilot, Jacques Cadranel   +3 more
openaire   +1 more source

Ulcerated nodules in a sporotrichoid distribution. [PDF]

, 2019
de Feraudy, Sebastien, Elsensohn, Ashley N, Hosking, Anna-Marie, Kraus, Christina N, Shiu, Jessica, Smith, Janellen   +5 more
core  

Concurrent EGFR mutation and ALK rearrangement in stage IV lung adenocarcinoma-a case report and a literature review. [PDF]

Porto Biomed J, 2021
Cipriano É, Magalhães H, Tavares C, Pinto J, Cirnes L, Estevinho F.   +5 more
europepmc   +1 more source